2,3-Diphenyl-N-(2-piperazin-1-ylethyl)furo[2,3-b]pyridin-4-amine

This compound is a small molecule belonging to the class of organic compounds known as 2,3-diphenylfurans. It features a furo[2,3-b]pyridine core substituted with diphenyl and piperazine moieties. It has been identified as an experimental compound with no current approved indications or marketed status. The molecule exhibits inhibitory activity against tyrosine-protein kinase Lck with an IC50 of approximately 210 nM. Its mechanism involves kinase inhibition which may be relevant for research in signal transduction pathways involving Lck kinase. No clinical trials or patents are currently associated with this drug. The developer and manufacturer information is not publicly available.

Other names

2,3-diphenyl-N-[2-(piperazin-1-yl)ethyl]furo(2,3-b)pyridin-4-amine2,3-Diarylfuro[2,3-b]pyridine-4-amine